TIAA-CREF Individual & Institutional Services’s Adaptive Biotechnologies ADPT Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$230K	Buy	+7,975	New	+$196K	﹤0.01%	676

Other funds holding ADPT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's ADPT Position: Q3 2026 in Review

TIAA-CREF Individual & Institutional Services opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 7,975 shares worth $230K. The stake represents ﹤0.01% of the portfolio and ranks #676 among its holdings.

244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

TIAA-CREF Individual & Institutional Services held 7,975 shares of Adaptive Biotechnologies worth $230K as of Q3 2026.
Adaptive Biotechnologies was a new TIAA-CREF Individual & Institutional Services position in Q3 2026.
Adaptive Biotechnologies made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q3 2026, its #676 holding.
244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q3 2026, filed 12 Nov 2026.